Select Page

4th EPHA Universal Access and Affordable Medicines Forum

Time for a New Deal: Challenging the status quo on medicines policy
 
#newdeal4meds

14 November

09:30-17:00

18 speakers

Over 5 sessions

Scotland House

Brussels

The annual one-day multi-stakeholder Forum on access to medicines in Europe organised by the European Public Health Alliance (EPHA).

The 4th EPHA Universal Access and Affordable Medicines Forum provided stimulating and lively discussions on the hottest topics in the access to medicines debate, including: pharma and medicines policies, affordability, R&D (research and development), innovation, transparency in pharmaceuticals, shortages, patient safety, health technology assessment (HTA).

speakers

participants

Twitter reach

Re-live the event

09:30 - 09:45 Welcome and introduction
  • Fiona Godfrey, Secretary General, European Public Health Alliance (EPHA) @fjgodfrey @EPHA_EU
09:45 - 11:10 EU plans around cancer: Hype VS substance
  • Denis Lacombe, Director-General, European Organisation for Research and Treatment of Cancer (EORTC) @EORTC
  • Kathi Apostolidis, President, European Cancer Patient Coalition (ECPC) @cancereu @kgapo
  • Carin Uyl-de Groot, Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam @ESHPM_EUR
  • Ward Rommel, Researcher, Kom op tegen Kanker, Access to Medicines Task-Force,
    European Cancer Leagues (ECL) @CancerLeagues @KOTKanker @WardRommel
  • Chantal Bélorgey, Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé – HAS) @HAS_sante
11:30 - 12:00 Access to medicines – high and unsustainable price levels: Keynote & brief exchange with Bjørn-Inge Larsen
  • Bjørn-Inge Larsen, Secretary-General, Ministry of Health and Care Services, Norway
  • Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA), Member Of The Management Board at European Medicines Agency (EMA) @ynatsis @EPHA_EU
13:00-14:25 An old new problem: Solutions to the medicines shortages in Europe
  • Vlad Mixich, Coordinator, Romanian Health Observatory – Board member, EPHA @mixich
  • Charlotte Roffiaen, EU advocacy advisor, France Assos Santé (FAS) @Fr_Assos_Sante @EU4Ublog
  • Aida Batista, Vice-President, European Association of Hospital Pharmacists (EAHP) @EAHPtweet @AidaBatista
  • Kasper Ernest, Secretary-General, European Association of Euro-Pharmaceutical Companies (EAEPC) @EAEPC_Brussels @KasperErnest
14:45-16:15 Pharmaceuticals, a secretive business: How to shed light into the black box?
  • Ellen t’ Hoen LLM, PhD, Medicines Law & Policy @MedsLawPolicy @ellenthoen
  • Audun Hågå, Head, Norwegian Medicines Agency
  • Marcel van Raaij, Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands @MarcelvanRaaij
  • Fergal O’ Regan, Head of Enquiries, European Ombudsman @EUombudsman
  • Alexander Roediger, Executive Director Oncology Policy, Europe, Middle East, Africa and Canada (EMEAC), MSD International @MSDInvents
16:15-16:30 Closing remarks
16:30-17:30 Networking reception

Event Gallery

In the Press

Speakers

Aida Batista

Vice-President, European Association of Hospital Pharmacists (EAHP)

 

Charlotte Roffiaen

EU advocacy advisor, France Assos Santé (FAS)

 

Rohit Malpani

Board member, UNITAID

 

Ward Rommel

Access to Medicines Task-Force, European Cancer Leagues (ECL)

 

Fergal O' Reagan

European Ombudsman

 

Audun Hågå

Head, Norwegian Medicines Agency

 

Alexander Roediger

MSD International

 

Fiona Godfrey

European Public Health Alliance (EPHA)

 

Kathi Apostolidis

President, European Cancer Patient Coalition (ECPC)

 

Marcel van Raaij

Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands

 

Bjørn-Inge Larsen

Secretary-General, Ministry of Health and Care Services, Norway

 

Chantal Bélorgey

Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé - HAS)

(tbc)

Ellen t’ Hoen LLM, PhD

Medicines Law & Policy

 

Vlad Mixich

Coordinator, Romanian Health Observatory – Board member, EPHA

 

Carin Uyl-de Groot

Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam

 

Denis Lacombe

Director-General, European Organisation for Research and Treatment of Cancer (EORTC)

 

Yannis Natsis

European Public Health Alliance (EPHA)

 

Kasper Ernest

Secretary-General, European Association of Euro-Pharmaceutical Companies (EAEPC)

 

The debate on social media

Past EPHA Universal Access and Affordable Medicines Forums

EPHA 2018 Universal Access and Affordable Medicines Forum

20 November 2018

2017 EPHA Universal Access & Affordable Medicines Forum

21 November 2017

2016 EPHA Universal Access and Affordable Medicines Forum

29 November 2016

Contact

Policy

Yannis Natsis

Policy Manager Universal Access and Affordable Medicines
yannis@epha.org
+32 2 233 3886

Press

Giulia Vettore

Communications Manager
giulia@epha.org
+32 2 233 3884

Logistics

Selena Goksel

Events Coordinator
selena@epha.org
+32 2 233 3875